Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (171-180 of 401) with videos related to

Pageof 41
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|June 30, 2025
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi StudyDinesh Shrikrishna, John Steer, Beverley Bostock, et al.
JACC. Advances|December 18, 2023
Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 TrialSiddharth M Patel, Marc P Bonaca, David A Morrow, et al.
European Heart Journal|November 11, 2022
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54Marc P Bonaca, KyungAh Im, Giulia Magnani, et al.
Journal of Cardiothoracic Surgery|January 20, 2025
Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registryMichael Schmoeckel, Matthias Thielmann, Keti Vitanova, et al.
European Heart Journal|August 31, 2010
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trialStefan James, Dominick J Angiolillo, Jan H Cornel, et al.
European Heart Journal. Acute Cardiovascular Care|January 7, 2015
Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patternsHéctor Bueno, Peter Sinnaeve, Lieven Annemans, et al.
European Heart Journal|September 28, 2021
Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic eventsJudit Cubedo, Teresa Padró, Gemma Vilahur, et al.
Platelets|October 17, 2013
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO studyRobert F Storey, Stefan K James, Agneta Siegbahn, et al.
Thrombosis and Haemostasis|December 9, 2016
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetesKatie A Greenhalgh, Mark W Strachan, Saad Alzahrani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary SyndromesThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
Pageof 41

Showing results (171-180 of 401) with videos related to

Sort By:
Pageof 41
International Journal of Chronic Obstructive Pulmonary Disease|June 30, 2025
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi StudyDinesh Shrikrishna, John Steer, Beverley Bostock, et al.
JACC. Advances|December 18, 2023
Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 TrialSiddharth M Patel, Marc P Bonaca, David A Morrow, et al.
European Heart Journal|November 11, 2022
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54Marc P Bonaca, KyungAh Im, Giulia Magnani, et al.
Journal of Cardiothoracic Surgery|January 20, 2025
Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registryMichael Schmoeckel, Matthias Thielmann, Keti Vitanova, et al.
European Heart Journal|August 31, 2010
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trialStefan James, Dominick J Angiolillo, Jan H Cornel, et al.
European Heart Journal. Acute Cardiovascular Care|January 7, 2015
Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patternsHéctor Bueno, Peter Sinnaeve, Lieven Annemans, et al.
European Heart Journal|September 28, 2021
Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic eventsJudit Cubedo, Teresa Padró, Gemma Vilahur, et al.
Platelets|October 17, 2013
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO studyRobert F Storey, Stefan K James, Agneta Siegbahn, et al.
Thrombosis and Haemostasis|December 9, 2016
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetesKatie A Greenhalgh, Mark W Strachan, Saad Alzahrani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary SyndromesThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
Pageof 41